DrugPatentWatch Database Preview
Details for Patent: 8,241,243
Which drugs does patent 8,241,243 protect, and when does it expire?
Patent 8,241,243 protects SUMAVEL DOSEPRO and is included in one NDA.
This patent has nine patent family members in eight countries.
This patent has nine patent family members in eight countries.
Summary for Patent: 8,241,243
| Title: | Needleless injector drug capsule and a method for filling thereof |
| Abstract: | A method for filling needleless injector capsules with liquid drug, whereby dissolved gas within the drug is replaced by a less soluble gas in order to reduce the inclusion of gas bubbles, or to prevent the growth of bubbles during storage and thereby prevent breakage of the capsules. |
| Inventor(s): | William; Henry (Cambridge, GB), Andrew; Lewis (Cambridge, GB) |
| Assignee: | Zogenix, Inc. (Emeryville, CA) |
| Application Number: | 10/496,357 |
|
Patent Claim Types: see list of patent claims | Formulation; Dosage form; |
Drugs Protected by US Patent 8,241,243
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endo Ventures Ltd | SUMAVEL DOSEPRO | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 022239-001 | Jul 15, 2009 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
Foreign Priority and PCT Information for Patent: 8,241,243
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| United Kingdom | 0127942.1 | Nov 21, 2001 |
| PCT Information | |||
| PCT Filed | November 21, 2002 | PCT Application Number: | PCT/GB02/05220 |
| PCT Publication Date: | June 05, 2003 | PCT Publication Number: | WO03/045479 |
Non-Orange Book US Patents Family Members for Patent 8,241,243
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 8,663,158 | Needleless injector drug capsule and a method for filling thereof | ➤ Sign Up |
| 8,118,771 | Needleless injector drug capsule and a method for filling thereof | ➤ Sign Up |
| 8,491,524 | Needleless injector drug capsule and a method for filling thereof | ➤ Sign Up |
| 8,241,244 | Needleless injector drug capsule and a method for filling thereof | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Family Members for US Patent 8,241,243
| Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Japan | 4351056 | ➤ Sign Up | |||
| Japan | 2005510307 | ➤ Sign Up | |||
| United Kingdom | 0127942 | ➤ Sign Up | |||
| European Patent Office | 1446177 | ➤ Sign Up | |||
| Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
